After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, PGEN falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Precigen Inc is $442.77M. A total of 1.6 million shares were traded on the day, compared to an average of 1.50M shares.
In the most recent transaction, Perez Jeffrey Thomas bought 58,823 shares of PGEN for 0.85 per share on Aug 09 ’24. After the transaction, the SVP, IP Affairs now owns 743,097 company shares. In a previous transaction on Aug 09 ’24, KIRK RANDAL J bought 23,529,411 shares at 0.85 per share. PGEN shares that Director owns now total 64,547,214.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, PGEN has a high of $2.17 and a low of $0.65.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. PGEN’s latest balance sheet shows that the firm has $108.66M in Cash & Short Term Investments as of fiscal 2021. There were $190.07M in debt and $34.65M in liabilities at the time. Its Book Value Per Share was -$0.05, while its Total Shareholder’s Equity was $107.35M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PGEN is Buy with a score of 4.00.
